Tipranavir

Results: 69



#Item
51201 1 to be the target.  2

201 1 to be the target. 2

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-07-08 15:14:02
521 DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH  ANTIVIRAL DRUGS ADVISORY COMMITTEE

1 DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH ANTIVIRAL DRUGS ADVISORY COMMITTEE

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-07-08 15:14:03
53Food and Drug Administration

Food and Drug Administration

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-06-20 14:31:16
54DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD[removed]ATTENTION PHARMACIST: Detach

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD[removed]ATTENTION PHARMACIST: Detach "Patient’s Instructions for Use” from package

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:57:04
55[removed], please? [Slide] Here is an example of a patient who failed without resistance, the single patient in protocol 4 who failed without resistance to any of the

[removed], please? [Slide] Here is an example of a patient who failed without resistance, the single patient in protocol 4 who failed without resistance to any of the

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-11-14 15:13:40
56PREZISTA (darunavir) Label

PREZISTA (darunavir) Label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-11-08 14:29:20
57Darunavir Clinical Pediatric Review

Darunavir Clinical Pediatric Review

Add to Reading List

Source URL: www.fda.gov

Language: English
58Tipranavir / Protease inhibitors / Pyridines / Organofluorides

Food and Drug Administration Center for Drug Evaluation and Research (CDER) Antiviral Drugs Advisory Committee May 19, 2005

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-05-25 15:52:56
59ABCD Subject: Important Safety Information: Intracranial Hemorrhage in Patients Receiving Aptivus® (tipranavir) capsules Boehringer Ingelheim Pharmaceuticals, Inc.

ABCD Subject: Important Safety Information: Intracranial Hemorrhage in Patients Receiving Aptivus® (tipranavir) capsules Boehringer Ingelheim Pharmaceuticals, Inc.

Add to Reading List

Source URL: www.fda.gov

Language: English
60HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PREZISTA safely and effectively. See Full Prescribing Information for PREZISTA. PREZISTA (darunavir) Tablet, Film Co

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PREZISTA safely and effectively. See Full Prescribing Information for PREZISTA. PREZISTA (darunavir) Tablet, Film Co

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-10-25 14:50:21